Published by Coherent Market Insights
Posted on September 21, 2021
4 min readLast updated: February 4, 2026
The Dilated Cardiomyopathy Market is set for exponential growth by 2027, driven by heart failure cases and medical advancements.
Coherent Market Insights report on the Dilated Cardiomyopathy Market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2021 to 2027. The report provides the overall market value of the Dilated Cardiomyopathy Market for the period of 2021 to 2027, with 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the Dilated Cardiomyopathy Market for the forecast period.
The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/514
Dilated cardiomyopathy is a medical condition in which the heart’s muscle tissue becomes stretched, weakened, or has some other structural defect. Dilated cardiomyopathy most commonly occurs in people with a history of heart disease and may also be hereditary. There is currently no known cause for Dilated Cardiomyopathy, but there are several possible genetic or environmental factors that may increase the chance of developing Dilated Cardiomyopathy or even heart disease. A few of the possible risk factors include:
Dilated cardiomyopathy can produce symptoms such as pain or discomfort in the chest, usually near the center of the chest, dizziness, and irregular heartbeat, nausea, vomiting, and swelling in the abdomen. Abnormal heart rhythms may also be present, particularly faster heartbeats or shallow, irregular rhythms. When Dilated Cardiomyopathy occurs, there are three types of treatments. These include surgery, medications, and lifestyle changes.
Owing the increase in congestive heart failure cases in the world is the main factor that is driving the growth of the global dilated cardiomyopathy market. For instance, according to the European Society of Cardiology, around 26 million people in the world are suffering from heart failure. Moreover, continuous research and development in the field of medical studies in order to launch accurate drugs to treat the condition is also enhancing the growth of the global dilated cardiomyopathy market.
Surgery for Dilated Cardiomyopathy involves the surgical removal of affected tissue, such as a lung or a section of the heart. Medications and lifestyle changes, however, are most often used to treat Dilated Cardiomyopathy. Oftentimes, patients are given a shock collar to help lower their heart rate, as well as fluid medication, and often a course of anti-arrhythmia medicine, such as Atripla. Some patients with Dilated Cardiomyopathy do not respond to medication or physical therapy and are placed on a waiting list for surgery. Waiting for the symptoms of Dilated Cardiomyopathy to subside before seeking treatment can result in a significant loss of quality of life. However, the unavailability of accurate drugs for treating this condition is the main restraining factor that is hindering the growth of the global dilated cardiomyopathy market.
Owing to the increase of cardiovascular issues in the region, North America is witnessing high demand in the global dilated cardiomyopathy market. For instance, according to the Centers for Disease Control and Prevention, around 6.2 million adults in the United States region suffer from heart failure. Moreover, continues developments in the healthcare sector in the region are also boosting the market growth. Owing to such factors there have been significant developments in the global dilated cardiomyopathy market. For instance, in August 2019, MyoKardia, Inc., introduced the 2nd Annual Myoseeds Research Grant Program, for promoting independent research in biology.
Top Key Players Include In Dilated Cardiomyopathy Market: Pfizer Inc., Johnson & Johnson Pvt. Ltd., Array BioPharma, AstraZeneca, GlaxoSmithKline Plc., and Sanofi.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/514
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Exponential Growth Expected for Dilated Cardiomyopathy Market with Complete SWOT Analysis by Forecast to 2021 to 2027 appeared first on Gatorledger.
The article focuses on the growth and analysis of the Dilated Cardiomyopathy Market from 2021 to 2027.
Increase in heart failure cases and advancements in medical research are key growth drivers.
Key players include Pfizer Inc., AstraZeneca, and Sanofi.
Explore more articles in the Research Reports category
